Deep Learning Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using… AIT News Desk May 22, 2022 Genesis Therapeutics, a company pioneering artificial intelligence technologies to create medicines for patients with severe and unmet medical…
News Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans AIT News Desk Jun 1, 2020 First patients have been dosed in a Phase 1 study of LY-CoV555, the lead antibody from Lilly's collaboration with AbCellera The placebo-controlled…